[ACTIVATION OF FIBRINOLYSIS BY THE PROLONGED ORAL ADMINISTRATION OF A NICOTINIC DERIVATIVE IN ARTERIOSCLEROTIC SUBJECTS].
D000284:Administration, Oral; D001161:Arteriosclerosis; D001794:Blood Pressure; D001798:Blood Proteins; D002784:Cholesterol / Q000097:blood*; D005341:Fibrinolysin; D005342:Fibrinolysis; D005853:Geriatrics; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins; D008111:Liver Function Tests; D009525:Niacin; D010600:Pharmacology; D010743:Phospholipids
D001798:Blood Proteins; D008055:Lipids; D008074:Lipoproteins; D010743:Phospholipids; D009525:Niacin; D002784:Cholesterol; D005341:Fibrinolysin
ARTERIOSCLEROSIS; BLOOD CHOLESTEROL; BLOOD LIPIDS; BLOOD PRESSURE; BLOOD PROTEINS; FIBRINOLYSIN; FIBRINOLYSIS; GERIATRICS; LIPOPROTEINS; LIVER FUNCTION TESTS; NICOTINIC ACID; PHARMACOLOGY; PHOSPHOLIPIDS
ATTIVAZIONE DELLA FIBRINOLISI DA SOMMINISTRAZIONE PROLUNGATA PER VIA ORALE DI UN DERIVATO NICOTINICO IN SOGGETTI ARTERIOSCLEROTICI.